Investing Profile

Christopher Gagliardi

InvestorVC

Principal, Sanofi Ventures at Sanofi Ventures

sanofiventures.com/team/index...Boston, Massachusetts

Your Intro Paths to Christopher Gagliardi

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Christopher is a member of

University of North Carolina at Chapel Hill Network

90 CONNECTIONS

L.E.K. Consulting Network

72 CONNECTIONS

Sanofi Network

40 CONNECTIONS

Sanofi Network

40 CONNECTIONS

Find Christopher Gagliardi on

Current Investing Position

Sanofi Ventures Principal

Investment Range

$5.0M - $10.0M

Sweet Spot

$7.5M

Investments On Record

Christopher Gagliardi is on these Sector & Stage Rankings

Medical Devices (Seed)Pharmaceuticals (Seed)Consumer Health (Series A)Medical Devices (Series A)BioTech (Seed)Consumer Health (Seed)Pharmaceuticals (Series A)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)Boston / New England Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Christopher Gagliardi's Investments On Record (6)

Company	StageDateRound Size	Total Raised
AdvanCell	Series DJul 2026$320M Series CFeb 2025$110M	$430M
Co-investors: Jamil Beg (5am Ventures), Bali Muralidhar (Abingworth)
QuantX Biosciences	Series BFeb 2026$85M	$85M
Co-investors: Paulina Hill (Polaris Partners)
Lifordi Immunotherapeutics	Series UnknownNov 2025$42M	$110M
Co-investors: Steven Gillis (ARCH Venture Partners), Bruce Booth (Atlas Venture)
Sudo Biosciences	Series BFeb 2024$30M Series BDec 2023$120M	$180M
Co-investors: Daniel Estes (Frazier Life Sciences), Shinichiro Fuse
Minervax	Series UnknownOct 2023$57M Series CDec 2022$23M Series BDec 2020$58M	$140M
Co-investors: Vincent Brichard (EQT Group), Veronica Gambillara Fonck (Pureos Bioventures), Kabeer Aziz (Adjuvant Capital)
i2o Therapeutics	SeedApr 2020$4M	$4M
Co-investors: Katie Ellias (T1D Fund)

Christopher Gagliardi's Experience

Marine Resources Center Marine Biological LaboratoryPresent

Research Assistant/Intern, Department of Inorganic Chemistry Technische Universität GrazPresent

Consultant L.E.K. ConsultingPresent

Director of Investments, Sanofi Ventures SanofiPresent

Board Member i2o TherapeuticsPresent

Board Member Minervax ApSPresent

Board Observer Matchpoint TherapeuticsPresent

Board Observer NextPoint Therapeutics, Inc.Present

Principal, Sanofi Ventures SanofiPresent

Board Observer Avilar TherapeuticsPresent

Board Member Sudo BiosciencesPresent

Board Observer Atalanta TherapeuticsPresent

Board Member AdvanCellPresent

Board Observer Lifordi Immunotherapeutics, Inc.Present

Board Member QuantX BiosciencesPresent

Board Observer Diagonal TherapeuticsPresent

Board Observer Epicrispr BiotechnologiesPresent

Christopher Gagliardi's Education

The University of North Carolina at Chapel Hill Doctor of Philosophy (Ph.D.) Inorganic Chemistry

University of North Carolina at Chapel Hill Doctor of Philosophy (Ph.D.) Inorganic Chemistry

Roger Williams University Bachelor of Science (B.S.) Chemistry Bachelor of Science (B.S.) Biology

Investors who invest with Christopher Gagliardi

Scouts & Angels Affiliated With Christopher Gagliardi